Hydrox Laboratories – FDA 483, Jun 24, 2021
Hydrox Laboratories in Elgin, IL, was inspected by the FDA and received a Form 483 with nine observations indicating significant deficiencies in quality control and manufacturing practices. The inspection revealed failures in microbial testing, equipment cleaning and maintenance, adherence to written procedures, and the investigation of discrepancies and out-of-specification results. These issues suggest a systemic lack of control over critical aspects of drug product manufacturing, potentially impacting product safety and quality.
ID · aaa3fe6b-307d-44ab-8006-76e877d1fec3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.